Clinical Trials Browser

Phase 1/2 × Terminated × Hormone Refractory Prostate Cancer × Clear all

NCT00906243 2012-04-04

RNActive®-Derived Therapeutic Vaccine

Phase 1/2 Terminated

6 enrolled 5 charts

Hormone Refractory Prostate Cancer